CES1 and colorectal carcinoma: CES1 expression was upregulated in consensus molecular subtypes (CMS)4 and CMS2 tumors and correlated with worse clinical outcomes in overweight CRC patients [258,259,260], suggesting a role for CES1 in the pathogenesis of CRC.